These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 14514338)

  • 1. Phenotypes defined by the "Vienna Classification" in 100 Hungarian patients with Crohn's disease.
    Nemetz A; Molnar T; Zagoni T; Kovacs A; Tulassay Z; Nagy F; Salvador Peña A
    Rev Esp Enferm Dig; 2003 Aug; 95(8):533-8, 527-33. PubMed ID: 14514338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
    Lakatos L; Lakatos PL; Willheim-Polli C; Reinisch W; Ferenci P; Tulassay Z; Molnár T; Kovács A; Papp J; Szalay F;
    Orv Hetil; 2004 Jul; 145(27):1403-11. PubMed ID: 15320482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does cigarette smoking influence the phenotype of Crohn's disease? Analysis using the Montreal classification.
    Aldhous MC; Drummond HE; Anderson N; Smith LA; Arnott ID; Satsangi J
    Am J Gastroenterol; 2007 Mar; 102(3):577-88. PubMed ID: 17338736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation of Crohn's disease. association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery.
    Lakatos PL; Szalay F; Tulassay Z; Molnar T; Kovacs A; Gasztonyi B; Papp J; Lakatos L;
    Hepatogastroenterology; 2005; 52(63):817-22. PubMed ID: 15966211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour.
    Alvarez-Lobos M; Arostegui JI; Sans M; Tassies D; Piu J; Reverter JC; Pique JM; Yagüe J; Panés J
    Aliment Pharmacol Ther; 2007 Feb; 25(4):429-40. PubMed ID: 17269998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Different approaches for medical or surgical management of Crohn's disease: the importance of the classification of Vienna].
    Colombo PL; Benedetti M; Tinozzi FP; Ticozzelli E; Maroni N; Di Sabatino A; Tinozzi S
    Ann Ital Chir; 2006; 77(6):485-96. PubMed ID: 17343232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it time to re-classify Crohn's disease?
    Fedorak RN
    Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():99-106. PubMed ID: 15588801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and risk factors for primary surgery in 205 patients with Crohn's disease: analysis of a South China cohort.
    Song XM; Gao X; Li MZ; Chen ZH; Chen SC; Hu PJ; He YL; Zhan WH; Chen MH
    Dis Colon Rectum; 2011 Sep; 54(9):1147-54. PubMed ID: 21825896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of clinical behaviour in Crohn's disease: predictive factors of penetrating complications.
    Papi C; Festa V; Fagnani C; Stazi A; Antonelli G; Moretti A; Koch M; Capurso L
    Dig Liver Dis; 2005 Apr; 37(4):247-53. PubMed ID: 15788208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life.
    Casellas F; Vivancos JL; Sampedro M; Malagelada JR
    Am J Gastroenterol; 2005 Dec; 100(12):2737-42. PubMed ID: 16393228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
    Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
    Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and serological markers to identify phenotypic subgroups in a Dutch Crohn' s disease population.
    Linskens RK; Mallant-Hent RC; Murillo LS; von Blomberg BM; Alizadeh BZ; Peña AS
    Dig Liver Dis; 2004 Jan; 36(1):29-34. PubMed ID: 14971813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease.
    Louis E; Collard A; Oger AF; Degroote E; Aboul Nasr El Yafi FA; Belaiche J
    Gut; 2001 Dec; 49(6):777-82. PubMed ID: 11709511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.
    Barreiro-de Acosta M; Domínguez-Muñoz JE; Núñez-Pardo de Vera MC; Lozano-León A; Lorenzo A; Peña S
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):73-8. PubMed ID: 17206080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vienna classification of Crohn's disease: helpful or dispensable? A critical view].
    Leiss O; Börner N
    Z Gastroenterol; 2007 Mar; 45(3):265-72. PubMed ID: 17357958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of inflammatory bowel diseases in Veszprém county of Western Hungary between 1977 and 2001].
    Lakatos L; Mester G; Erdélyi Z; Balogh M; Szipócs I; Kamarás G; Lakatos PL
    Orv Hetil; 2003 Sep; 144(37):1819-27. PubMed ID: 14596020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
    Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course.
    Kim BC; Park S; Han J; Kim JH; Kim TI; Kim WH
    Dig Liver Dis; 2007 Jul; 39(7):610-6. PubMed ID: 17531556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically active Crohn's disease in the presence of a low C-reactive protein.
    Florin TH; Paterson EW; Fowler EV; Radford-Smith GL
    Scand J Gastroenterol; 2006 Mar; 41(3):306-11. PubMed ID: 16497618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hla-B genotype in Japanese patients with Crohn's disease.
    Kinouchi Y; Matsumoto K; Negoro K; Takagi S; Takahashi S; Hiwatashi N; Shimosegawa T
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S10-4. PubMed ID: 14530653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.